COUNCODOSNSECountry Condo's Limited· PharmaceuticalsMediumNeutral
Announced Thu, 14 Aug · 16:36 IST

Country Condo's Limited has informed the Exchange regarding Board meeting held on August 14, 2025.

Revenue Growth 20pctResults View source PDF

COUNCODOS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Country Condo's Limited's board, at its meeting on August 14, 2025, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Net sales/income from operations jumped sharply to ₹354.40 lakhs from ₹120.24 lakhs in Q1 FY25, a rise of about 195%, likely driven by land development activity. However, total expenses fell to ₹336.36 lakhs from ₹397.63 lakhs, helping the company post a profit before tax of ₹18.04 lakhs (vs ₹25.40 lakhs last year). Net profit after tax came in at ₹13.82 lakhs (vs ₹19.35 lakhs), translating to an EPS of ₹0.02. The limited review report by P. Murali & Co. is clean, with no qualifications or observations.

Likely market impact

Despite a strong revenue jump, bottom-line growth has not followed, with PAT actually declining year-on-year, suggesting margin pressure and higher costs in the quarter. For shareholders, this mixed picture — top-line strength without profit growth — is a neutral-to-slightly-negative signal in the short term.